All the economic studies of genomic tests for breast cancer rely on modeling rather than randomized controlled trials or other direct trial data.
Robert D. Lieberthal, PhD
Advertisement
Articles by Robert D. Lieberthal, PhD
Advertisement
Latest Updated Articles
- Economics of Genomic Testing for Women With Breast Cancer
Published: December 23rd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
3
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
4
Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD
5
